Microbot Medical: sets shareholder nomination deadline; patents announced

What happened

• The filing says that on Oct 14, 2026 the board voted to hold the 2026 annual meeting of stockholders on Dec 14, 2026; the record date is Oct 15, 2026.
• The filing says the company disseminated a press release on Oct 20, 2026 announcing it has received several new patent approvals across the U.S., Japan, China and Canada and that it now holds 44 issued patents and 49 pending patent applications across North America, Europe, Israel, and Asia.

Key details

• The deadline for qualified stockholder proposals submitted under Rule 14a-8 for inclusion in the company’s proxy materials is the close of business on Oct 27, 2026.
• Any qualified stockholder seeking to have a nominee included in the company’s proxy materials must provide notice on a Schedule 14N and file it with the SEC on or before Oct 30, 2026 (as stated in the filing).
• Stockholder proposals must be received at the company’s principal executive offices at 175 Derby St., Bld. 27, Hingham, MA 02043, addressed to the Secretary.

Why it may matter

• Item 5.08 (shareholder director nominations) was reported and covers the annual meeting date, the record date and the deadlines and procedures for submitting stockholder proposals and nominations under Rule 14a-8 and Schedule 14N.
• Item 7.01 (Regulation FD disclosure) was reported and covers the press release about new patent approvals and the company’s stated patent counts.
• A filing does not show why the insider traded or why the company acted.